Chemours Co Stock
€15.65
Your prediction
Pros and Cons of Chemours Co in the next few years
Pros
Cons
Performance of Chemours Co vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemours Co | 1.360% | 9.155% | -10.622% | 16.660% | 51.670% | -42.825% | -30.933% |
| Newmarket Corp. | 0.000% | -8.108% | 4.508% | 6.695% | -14.286% | 61.392% | 58.385% |
| Quaker Chemical Corp. | 0.970% | -7.207% | -31.333% | -12.712% | -14.876% | - | - |
| Axalta Coating Systems Ltd. | 0.830% | -5.512% | -16.084% | -24.051% | -13.043% | -7.692% | -1.639% |
Comments
News
Why Chemours Plunged Today
Shares of European chemicals company Chemours (NYSE: CC) fell 16.8% on Friday, as of 2:46 p.m. EDT.
The chemicals giant reported lackluster earnings today and also provided guidance that merely met
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet
New York City-based Alta Fundamental Advisers initiated a new position in The Chemours Company (NYSE:CC), acquiring 800,000 shares valued at an estimated $12.67 million, according to a November 13
Luminus Trims Its Hefty Chemours Position
Luminus Management LLC reduced its stake in The Chemours Company (NYSE:CC) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC


